The Use of Release-Active Antibody-Based Preparations for Vertigo Prevention in Adults
| Autor: | V. V. Barchukov, Yu. L. Dugina, E. S. Zhavbert, Oleg I. Epstein |
|---|---|
| Rok vydání: | 2015 |
| Předmět: |
Adult
Male Coriolis Force medicine.medical_specialty Cannabinoid receptor Adolescent Nitric Oxide Synthase Type III Acceleration Primary Dysautonomias Pharmacology Severity of Illness Index Antibodies General Biochemistry Genetics and Molecular Biology Young Adult Double-Blind Method Receptor Cannabinoid CB1 Enos Internal medicine Vertigo Space Motion Sickness medicine Humans Receptor biology Chemistry S100 Proteins Nausea General Medicine Middle Aged biology.organism_classification Drug Combinations Endocrinology biology.protein Female Vestibule Labyrinth Antibody |
| Zdroj: | Bulletin of Experimental Biology and Medicine. 160:61-63 |
| ISSN: | 1573-8221 0007-4888 |
| Popis: | The effectiveness of antibody-based release-active preparations Impaza (antibodies to eNOS), Tenoten (antibodies to brain-specific protein S-100), Dietressa (antibodies to type 1 cannabinoid receptor), Brizantin (combined preparation, antibodies to brain-specific protein S-100 and type 1 cannabinoid receptor), and Divaza (combined preparation, antibodies to brain-specific protein S-100 and eNOS) in the prevention of vertigo was studied on the model of intermittent accumulation of Coriolis accelerations (ICCA). Modification of activity of vestibular receptors and signal systems by release-active preparations contributed to an increase in ICCA tolerance time. Combined preparation Impaza possessed the most significant antinaupathic properties. Brizantin was less potent in this respect. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink